β2-Adrenoreceptor Agonists, Montelukast, and Parkinson Disease Risk.
Liu B, Svenningsson P, Ludvigsson JF, Lundholm C, Wallin J, Larsson H, Sjölander A, Williams DM, Pedersen NL, Wirdefeldt K.
Liu B, et al. Among authors: larsson h.
Ann Neurol. 2023 May;93(5):1023-1028. doi: 10.1002/ana.26638. Epub 2023 Mar 23.
Ann Neurol. 2023.
PMID: 36897287